Aillis

Tokyo, Japan · Founded 2017 · Privately Held (backing)

Developer of an artificial intelligence-equipped pharyngoscopy system designed to diagnose infectious diseases from pharyngeal photographs. Aillis is based in Tokyo, Japan and was founded in 2017. Its last reported valuation was $125 million in Apr 2025. It has raised $54.6 million.

Last reported valuation
$125.2M
Oct 2026
Priced at
—
Total raised
$54.6M
Last round
—
No prints on record

No secondary trades in Aillis shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Aillis with a free account
  • ·The complete investor list: 27 names
  • ·Watch Aillis: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Where Aillis prices come from

Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Aillis stock.